Found: 625
Select item for more details and to access through your institution.
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Randomized Trial Comparing Proactive, High-Dose versus Reactive, Low-Dose Intravenous Iron Supplementation in Hemodialysis (PIVOTAL): Study Design and Baseline Data.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Adherence to ESC cardiac resynchronization therapy guidelines: findings from the ESC CRT Survey II.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Remote monitoring of implantable cardioverter-defibrillators and resynchronization devices to improve patient outcomes: dead end or way ahead?
- Published in:
- 2019
- By:
- Publication type:
- journal article
European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society.
- Published in:
- 2016
- By:
- Publication type:
- journal article
European cardiac resynchronization therapy survey II: rationale and design.
- Published in:
- 2015
- By:
- Publication type:
- journal article
European Cardiac Resynchronization Therapy Survey II: rationale and design.
- Published in:
- EP: Europace, 2015, v. 17, n. 1, p. 137, doi. 10.1093/europace/euu312
- By:
- Publication type:
- Article
European Cardiac Resynchronization Therapy Survey II: rationale and design.
- Published in:
- EP: Europace, 2015, v. 17, n. 1, p. 137, doi. 10.1093/europace/euu312
- By:
- Publication type:
- Article
Orthostatic Hypotension and Incident Heart Failure in Community-Dwelling Older Adults.
- Published in:
- Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2014, v. 69A, n. 2, p. 223, doi. 10.1093/gerona/glt086
- By:
- Publication type:
- Article
Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-12385-0
- By:
- Publication type:
- Article
Inflammation, Cholesterol Levels, and Risk of Mortality Among Patients Receiving Dialysis.
- Published in:
- 2004
- By:
- Publication type:
- Letter
Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia.
- Published in:
- European Journal of Endocrinology, 2001, v. 145, n. 6, p. 727, doi. 10.1530/eje.0.1450727
- By:
- Publication type:
- Article
Short-term Mortality Risk in Emergency Department Acute Heart Failure.
- Published in:
- Academic Emergency Medicine, 2011, v. 18, n. 9, p. 947, doi. 10.1111/j.1553-2712.2011.01150.x
- By:
- Publication type:
- Article
Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 2, p. 372, doi. 10.1093/ndt/gfac157
- By:
- Publication type:
- Article
Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 7, p. 1261, doi. 10.1093/ndt/gfab336
- By:
- Publication type:
- Article
Investigating new treatment opportunities for patients with chronic kidney disease in type 2 diabetes: the role of finerenone.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 6, p. 1014, doi. 10.1093/ndt/gfaa294
- By:
- Publication type:
- Article
Defects in insulin action in chronic heart failure.
- Published in:
- Diabetes, Obesity & Metabolism, 2000, v. 2, n. 4, p. 203, doi. 10.1046/j.1463-1326.2000.00058.x
- By:
- Publication type:
- Article
Atrial natriuretic peptide and related peptides.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2007, v. 45, n. 10, p. 1259, doi. 10.1515/CCLM.2007.274
- By:
- Publication type:
- Article
Ghidul ESC de diagnostic şi tratament al insuficienţei cardiace acute şi cronice 2016.
- Published in:
- 2017
- By:
- Publication type:
- Calendar
Ghidul ESC de diagnostic şi tratament al insuficienţei cardiace acute şi cronice 2012.
- Published in:
- Romanian Journal of Cardiology, 2013, v. 23, n. 3, p. 245
- By:
- Publication type:
- Article
Risk of urogenital infections in non-diabetic patients treated with sodium glucose transporter 2 (SGLT2) inhibitors. Systematic review and meta-analysis.
- Published in:
- Archives of Italian Urology & Andrology / Archivio Italiano di Urologia Andrologia, 2023, v. 95, n. 2, p. 112, doi. 10.4081/aiua.2023.11509
- By:
- Publication type:
- Article
High cardiovascular event rates occur within the first weeks of starting hemodialysis.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Development and validation of a predictive mortality risk score from a European hemodialysis cohort.
- Published in:
- Kidney International, 2015, v. 87, n. 5, p. 996, doi. 10.1038/ki.2014.419
- By:
- Publication type:
- Article
The relevance of congestion in the cardio-renal syndrome.
- Published in:
- Kidney International, 2013, v. 83, n. 3, p. 384, doi. 10.1038/ki.2012.406
- By:
- Publication type:
- Article
Novel biomarkers in heart failure and cardio-oncology.
- Published in:
- Polish Heart Journal / Kardiologia Polska, 2019, v. 77, n. 3, p. 329, doi. 10.5603/KP.2019.0051
- By:
- Publication type:
- Article
The importance of registries in today's heart failure therapies.
- Published in:
- Polish Heart Journal / Kardiologia Polska, 2018, v. 76, n. 7, p. 1029, doi. 10.5603/KP.2018.0133
- By:
- Publication type:
- Article
Wytyczne ESC dotyczące diagnostyki i leczenia ostrej i przewlekłej niewydolności serca w 2016 roku.
- Published in:
- Polish Heart Journal / Kardiologia Polska, 2016, v. 74, n. 10, p. 1037, doi. 10.5603/KP.2016.0141
- By:
- Publication type:
- Article
Effect of empagliflozin on total myocardial infarction events by type and additional coronary outcomes: insights from the randomized EMPA-REG OUTCOME trial.
- Published in:
- Cardiovascular Diabetology, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12933-024-02328-6
- By:
- Publication type:
- Article
Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trial.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01943-z
- By:
- Publication type:
- Article
Cardiovascular implications of COVID-19 versus influenza infection: a review.
- Published in:
- BMC Medicine, 2020, v. 18, n. 1, p. 1, doi. 10.1186/s12916-020-01816-2
- By:
- Publication type:
- Article
Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists.
- Published in:
- Diabetologia, 2024, v. 67, n. 2, p. 246, doi. 10.1007/s00125-023-06031-1
- By:
- Publication type:
- Article
Impact of empagliflozin on insulin needs in patients with heart failure and diabetes: An EMPEROR‐Pooled analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 7, p. 2578, doi. 10.1111/dom.15572
- By:
- Publication type:
- Article
Front Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. C1, doi. 10.1111/dom.15423
- By:
- Publication type:
- Article
Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. 191, doi. 10.1111/dom.15305
- By:
- Publication type:
- Article
Back Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. C4, doi. 10.1111/dom.15286
- By:
- Publication type:
- Article
The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. 2989, doi. 10.1111/dom.15197
- By:
- Publication type:
- Article
Cover Image.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1, doi. 10.1111/dom.15115
- By:
- Publication type:
- Article
Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1512, doi. 10.1111/dom.14999
- By:
- Publication type:
- Article
Front Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. C1, doi. 10.1111/dom.14995
- By:
- Publication type:
- Article
Front Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. C1, doi. 10.1111/dom.14960
- By:
- Publication type:
- Article
Effect of finerenone on the occurrence of vision‐threatening complications in patients with non‐proliferative diabetic retinopathy: Pooled analysis of two studies using routine ophthalmological examinations from clinical trial participants (ReFineDR/DeFineDR)
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. 894, doi. 10.1111/dom.14915
- By:
- Publication type:
- Article
Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon‐like peptide‐1 receptor agonist use.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 407, doi. 10.1111/dom.14883
- By:
- Publication type:
- Article
The effect of empagliflozin on the total burden of cardiovascular and hospitalization events in the Asian and non‐Asian populations of the EMPA‐REG OUTCOME trial of patients with type 2 diabetes and cardiovascular disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 4, p. 662, doi. 10.1111/dom.14626
- By:
- Publication type:
- Article
Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP‐1RA treatment: A subgroup analysis from the FIDELIO‐DKD trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 1, p. 125, doi. 10.1111/dom.14558
- By:
- Publication type:
- Article
Cognitive Function in Ambulatory Patients with Systolic Heart Failure: Insights from the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial.
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0113447
- By:
- Publication type:
- Article
Pharmacokinetics of Drugs in Cachectic Patients: A Systematic Review.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0079603
- By:
- Publication type:
- Article
Ghrelin and Its Analogues, BIM-28131 and BIM-28125, Improve Body Weight and Regulate the Expression of MuRF-1 and MAFbx in a Rat Heart Failure Model.
- Published in:
- PLoS ONE, 2011, v. 6, n. 11, p. 1, doi. 10.1371/journal.pone.0026865
- By:
- Publication type:
- Article
Identification of Chronic Heart Failure Patients with a High 12-Month Mortality Risk Using Biomarkers Including Plasma C-Terminal Pro-Endothelin-1.
- Published in:
- PLoS ONE, 2011, v. 6, n. 1, p. 1, doi. 10.1371/journal.pone.0014506
- By:
- Publication type:
- Article